Population Pharmacokinetics of Polymyxin B in Acutely Ill Adult Patients

Polymyxin B (PB) has reemerged as a common treatment against multidrug-resistant Gram-negative pathogens. However, nephrotoxicity remains a significant dose-limiting side effect, and contemporary pharmacokinetic (PK) data are limited. This study sought to evaluate PB exposure differences in various...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Antimicrob Agents Chemother
Hoofdauteurs: Miglis, Cristina, Rhodes, Nathaniel J., Avedissian, Sean N., Kubin, Christine J., Yin, Michael T., Nelson, Brian C., Pai, Manjunath P., Scheetz, Marc H.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society for Microbiology 2018
Onderwerpen:
Pharmacology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5826159/
https://ncbi.nlm.nih.gov/pubmed/29311071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01475-17
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items